Mayo Clinic Neuro-Oncology Summit: Translating Breakthroughs into Practice
This course offers Live (in-person) and Livestream (virtual) attendance options.

Course Directors: Wendy Sherman, M.D., Alfredo Quinones-Hinojosa, M.D., Maciej Mrugala, M.D., Ph.D., Terry Burns, M.D., Ph.D. and Rich Byrne, M.D.
February 26 - 27, 2027 - Mayo Clinic - Kinne Auditorium - Jacksonville, Florida
This course covers advanced topics in neuro-oncology, offering a review of advances in diagnosis and treatment of individuals with nervous system tumors. The course covers the latest advances in neurosurgery, radiation oncology, neurology, and medical oncology, discussing novel therapeutic approaches that are transforming clinical practice with personalized treatments.
Notify me when Updates in Neuro-Oncology 2027 registration opens
Signing up to be notified will ensure that you receive an email when registration opens. No additional information is available until then.
Target Audience
Nurse Practitioner, Physician, Physician Assistant, Resident/Fellow
Learning Objectives
- Discuss novel therapeutics for treatment of primary CNS tumors.
- Discuss novel therapeutics for tumor-predisposing conditions wit nervous system involvement.
- Discuss state-of-the-art diagnostic and therapeutic options for malignant CNS tumors.
- Evaluate the impact of molecular features on tumor behavior, therapeutic selection, and response to therapy.
- Recognize the value of a multidisciplinary approach to patients with CNS tumors.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
Additional Information
| Attachment | Size |
|---|---|
| 183.87 KB |
Friday, February 26, 2027 | |
7:00 - 8:00 a.m. | Registration & Continental Breakfast |
8:00 - 8:10 a.m. | Welcome Wendy Sherman, M.D. |
Low Grade Glioma Part 1 Moderator: Wendy Sherman, M.D. | |
8:10 – 8:30 a.m.
| Beyond the WHO: Emerging Classifications Ken Aldape, M.D. |
8:30 – 8:50 a.m.
| Advanced Spectroscopy in Preoperative Diagnosis Derek Johnson, M.D. |
8:50 – 9:10 a.m. | Mayo Clinic Experience: Liquid Biopsy and CSF DNA for Longitudinal Glioma Monitoring Terry Burns, M.D., Ph.D. |
9:10 – 9:20 a.m. | Interactive Q & A Panel |
9:20 – 9:35 a.m. | Refreshment Break & Exhibits |
Low Grade Glioma Part 2 Moderator: Ugur Sener | |
9:35 – 9:55 a.m.
| Modern Use of Radiation Therapy in Low Grade Glioma Kevin Zhang, M.D. |
9:55 – 10:5 a.m.
| Point/Counterpoint: IDH Inhibition Wendy Sherman, M.D. & Shannon Fortin Ensign, M.D., Ph.D. |
10:15 – 10:35 a.m. | Tumor Board Speakers from Part 1 and Part 2 |
10:35 – 10:50 a.m. | Interactive Q & A Panel |
10:50 - 11:05 a.m. | Refreshment Break & Exhibits |
High Grade Glioma Moderator: Christine Cordova | |
11:05 – 11:25 a.m.
| Current and Future Medical Therapies: Including Targeted Modalities Sani Kizilbash, M.D., M.P.H. |
11:25 a.m. – 11:45 a.m.
| Current & Future Immuno Modalities Jian Campian, M.D., Ph.D. |
11:45 – 12:05pm | CarT Cells in High Grade Glioma Hong Qin, M.D., Ph.D. |
12:05pm – 12:20pm | Interactive Q & A Panel |
12:20 – 1:20 p.m. | Lunch, Networking, Exhibits and Poster Session |
Survivorship Moderator: Maisha Robinson | |
1:20 – 1:40pm | Innovation in Brain Tumor Rehabilitation Geneveive Marshall, D.O. |
1:40 -2:00 | Palliative Care Topic Maisha Robinson, M.D. |
2:00 – 2:20 | Neuro-Cognitive Preservation Leslie Baxter, Ph.D. |
2:20 – 2:40 | Interactive Q&A |
Saturday, February 27, 2027 | |
7:00 - 8:00 a.m. | Registration & Continental Breakfast |
8:00 – 8:10am | Welcome Wendy Sherman, M.D. |
Skull Base Moderator: Terry Burns | |
8:10 – 8:30 a.m.
| Meningioma: From Bench to Bedside Victoria Clark, M.D., Ph.D. |
8:30 – 8:50 a.m.
| Meningioma: Radiation Therapies |
8:50 – 9:10 a.m.
| Endocrine Topic Susan Samson, M.D., Ph.D. |
9:10 – 9:30 a.m.
| Advances in Skull Base Surgery & NF1 Gelareh Zadeh, M.D., Ph.D. |
9:30 – 9:45 a.m. | Interactive Q & A |
9:45 – 10:00 a.m. | Refreshment Break & Exhibits |
Brain Mets Moderator: Daniel Trifiletti, MD (FLA) | |
10:00 – 10:20 a.m.
| LITT: innovative uses TBD |
10:20 – 10:40 a.m. | Improving Outcomes and Minimizing Risk with Radiation for Brain Mets Jennifer Peterson, M.D. |
10:40 – 11:00 a.m.
| Advances on Medical Management of Brain ets TBD |
11:00 – 11:20 a.m. | Current and Future Management of Leptomeningeal Metastases Maciej Mrugala, M.D., Ph.D. |
11:20 a.m. – 11:40 a.m. | Tumor Board |
11:40 – 12:00 pm | Interactive Q &A |
12:00 – 1:00 p.m. | Lunch, Networking, & Exhibits |
Innovation Moderators: Maciej Mrugala (AZ) | |
1:00 – 1:20 p.m.
| AI and Clinical Trials/Neuro-Oncology Anywhere Ugur Sener, M.D. |
1:20 – 1:40 | Device Innovation in Neuro-oncology Michael Ruff, M.D. |
1:40 – 2:00 | AI in Neuro- Oncology Tumor Diagnostic Ken Aldape, M.D. |
2:00 – 2:20 | Interactive Q &A |
All travel and lodging expenses are the sole responsibility of the individual registrant.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 9.75 ABS - Accredited CME
- 9.75 AMA PRA Category 1 Credit™
- 9.75 ANCC
Thank you for your interest in Updates in Neuro-Oncology 2027. This course is currently in the early planning stages. If you’d like to be notified when opportunities become available, please add your name to our Notify Me list. Signing up to be notified will ensure that you receive an email when exhibitor information is available. No additional information is available until then.
Notify me when Updates in Neuro-Oncology 2027 registration opens
Signing up to be notified will ensure that you receive an email when registration opens. No additional information is available until then.
Before registering, please update your profile
To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity. This course is not approved for on-demand delivery.
Commitment to Belonging and Inclusion
Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which all individuals are valued, allowing all to achieve their fullest potential.
Every effort will be made to accommodate dietary requirements; however, some requests may not be feasible based on venue kitchen capabilities. Attendees will be contacted in advance if a dietary restriction cannot be fulfilled.
The Mayo Clinic School of Continuous Professional Development strives for fully accessible learning experiences. If you anticipate any barriers while attending this course, please reach out to the course coordinator who will be in touch with all registrants. If you need disability-related accommodations, please contact the Office of Wellness and Academic Support – Disability Access Services at MCCMS.DS@mayo.edu.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.

Facebook
X
LinkedIn
Forward